ZA200308271B - Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation. - Google Patents

Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation.

Info

Publication number
ZA200308271B
ZA200308271B ZA200308271A ZA200308271A ZA200308271B ZA 200308271 B ZA200308271 B ZA 200308271B ZA 200308271 A ZA200308271 A ZA 200308271A ZA 200308271 A ZA200308271 A ZA 200308271A ZA 200308271 B ZA200308271 B ZA 200308271B
Authority
ZA
South Africa
Prior art keywords
preparation
meiosis
aminosterol compounds
regulating medicaments
medicaments
Prior art date
Application number
ZA200308271A
Other languages
English (en)
Inventor
Thorsten Blume
Christa Hegele-Hartung
Peter Esperling
Original Assignee
Schering Ag Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag Novo Nordisk As filed Critical Schering Ag Novo Nordisk As
Publication of ZA200308271B publication Critical patent/ZA200308271B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200308271A 2001-03-26 2003-10-23 Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation. ZA200308271B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01250108A EP1245572A1 (en) 2001-03-26 2001-03-26 Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation

Publications (1)

Publication Number Publication Date
ZA200308271B true ZA200308271B (en) 2005-01-24

Family

ID=8181575

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200308271A ZA200308271B (en) 2001-03-26 2003-10-23 Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation.

Country Status (18)

Country Link
US (1) US6916921B2 (https=)
EP (2) EP1245572A1 (https=)
JP (1) JP2004534011A (https=)
KR (1) KR20030088043A (https=)
CN (1) CN1332975C (https=)
AU (1) AU2002315260B2 (https=)
BR (1) BR0208381A (https=)
CA (1) CA2438210A1 (https=)
CZ (1) CZ20032578A3 (https=)
HU (1) HUP0303643A2 (https=)
IL (1) IL157272A0 (https=)
MX (1) MXPA03008199A (https=)
NO (1) NO20034273L (https=)
PL (1) PL369576A1 (https=)
RU (1) RU2289587C2 (https=)
UA (1) UA75130C2 (https=)
WO (1) WO2002079220A2 (https=)
ZA (1) ZA200308271B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1514874A1 (en) * 2003-07-28 2005-03-16 Schering Aktiengesellschaft Thiomorpholino steroid compounds, the use thereof for the preparation of meiosis regulating medicaments and method for the preparation thereof
KR100689260B1 (ko) * 2005-05-24 2007-03-02 삼원산업주식회사 항산화성 스틸벤계 형광증백제 및 이의 합성방법

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1095167A (en) * 1963-12-05 1967-12-13 Shalom Sarel Amino-steroids
US3419661A (en) * 1964-01-13 1968-12-31 Univ Missouri Oral contraceptive for birds
DE1643004A1 (de) * 1967-02-07 1971-04-08 Schering Ag Bisnorcholenderivate und Verfahren zu ihrer Herstellung
DE1930473A1 (de) * 1969-06-14 1970-12-17 Schering Ag 22-N-substituierte (20R)-23,24-dinor-cholanderivate
US5716777A (en) 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
HUP9800731A3 (en) * 1995-03-06 2000-03-28 Novo Nordisk As Stimulation of meiosis
CA2224866A1 (en) 1995-06-23 1997-01-09 Novo Nordisk A/S Meiosis regulating compounds
JP2001506656A (ja) 1996-12-20 2001-05-22 ノボ ノルディスク アクティーゼルスカブ 減数分裂調節化合物
WO1999058549A1 (en) * 1998-05-13 1999-11-18 Novo Nordisk A/S Meiosis regulating compounds
EP1098652A2 (en) 1998-05-26 2001-05-16 Schering Aktiengesellschaft Treatment of infertility with camp-increasing compounds alone or in combination with at least one meiosis-stimulating compound
CN1353617A (zh) 1999-02-24 2002-06-12 诺沃挪第克公司 不孕症的治疗
AU2794000A (en) 1999-02-24 2000-09-14 Novo Nordisk A/S Treatment of infertility
CZ20012671A3 (cs) 1999-02-26 2002-01-16 Novo Nordisk A/S Způsob in vitro oplodnění s pouľitím kultivačního média obsahujícího sterol aktivující meiosu
CA2382908A1 (en) 1999-09-16 2001-03-22 Novo Nordisk A/S Composition for ivf
WO2001062260A2 (en) 2000-02-25 2001-08-30 Schering Aktiengesellschaft Improvement of implantation rate
ATE386495T1 (de) * 2001-02-06 2008-03-15 Novo Nordisk As Behältnis mit niedrigem sauerstoffgehalt, das ff- mas enthält
US6988613B2 (en) * 2001-02-06 2006-01-24 Novo Nordisk A/S Composition for IVF

Also Published As

Publication number Publication date
RU2003130228A (ru) 2005-04-10
PL369576A1 (en) 2005-05-02
IL157272A0 (en) 2004-02-19
JP2004534011A (ja) 2004-11-11
CA2438210A1 (en) 2002-10-10
WO2002079220A2 (en) 2002-10-10
NO20034273L (no) 2003-11-25
NO20034273D0 (no) 2003-09-25
CZ20032578A3 (cs) 2003-12-17
UA75130C2 (en) 2006-03-15
CN1332975C (zh) 2007-08-22
US6916921B2 (en) 2005-07-12
EP1245572A1 (en) 2002-10-02
AU2002315260B2 (en) 2008-04-03
HUP0303643A2 (hu) 2004-03-01
WO2002079220A3 (en) 2003-10-16
CN1543473A (zh) 2004-11-03
MXPA03008199A (es) 2004-01-29
US20020188143A1 (en) 2002-12-12
KR20030088043A (ko) 2003-11-15
HK1070900A1 (en) 2005-06-30
RU2289587C2 (ru) 2006-12-20
EP1401856A2 (en) 2004-03-31
BR0208381A (pt) 2004-06-15

Similar Documents

Publication Publication Date Title
IL160440A (en) Dihydropteridinones, method for producing the same and the use thereof as medicaments
AU2002337047A1 (en) Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
TWI315741B (en) A-isomaltosyltransferase, process for producing the same and use thereof
IL162669A0 (en) Antichlinergic agents, method for producing the same and use thereof as medicaments
HUP0401461A3 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
AU2003206760A1 (en) Anticholinergic agents, method for producing the same and use thereof as medicaments
IL151496A0 (en) Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
IL161893A0 (en) 5-Phenylpyrimidines, agents comprising the same, method for production and use thereof
AU2002318742A1 (en) Pullulan-containing powder, process for producing the same and use thereof
TWI318974B (en) Acylaminothiazole derivatives, their preparation and their therapeutic use
MXPA03006249A (es) Derivados de 2-arilimino-2,3-dihidrotiazoles, sus procesos de preparacion y su uso terapeutico.
AU2002233407A1 (en) 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
AU2796602A (en) Coniosetin and derivatives thereof, method for producing the same and use thereof
ZA200002546B (en) Sorbate-preserved compositions, method for the manufacture thereof and their use.
AU2002227966A1 (en) Coniosetin and derivatives thereof, method for producing the same and use thereof
MXPA03006162A (es) Derivados de mikanolida, su preparacion y sus usos terapeuticos.
IL158587A0 (en) Novel 5-thio-ss-d-xylopyranoside derivatives, preparation method thereof, pharmaceutical compositions containing same and the therapeutic use thereof
ZA200308271B (en) Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation.
IL161859A0 (en) 3-Heteroaryl-3.5-dihydro-4-oxo-4H-pyridazinoÄ4.5-BÜindole-1-carboxamide derivatives, their preparation and therapeutic use
MXPA03008636A (es) Derivados de isoquinuclidina, metodo para fabricar los mismos y agentes terapeuticos que contienen estos compuestos.
EP1338275A4 (en) Pharmaceutical composition, its use and method of making the same
IL159561A0 (en) Eurotinones and derivatives thereof, processes for preparing them, and their use
AU2002356719A1 (en) Agent for oral administration and method for producing the same
IL141804A0 (en) Benzotriazole-1-yl-uronium derivatives, process for their preparation and use thereof
AU2002246373A1 (en) Cupua seed-origin fat, process for producing the same and use thereof